Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
4.050
+0.080 (2.02%)
At close: Mar 11, 2026, 4:00 PM EDT
4.190
+0.140 (3.46%)
After-hours: Mar 11, 2026, 7:45 PM EDT
Cibus Market Cap
Cibus has a market cap or net worth of $273.6 million as of March 11, 2026. Its market cap has increased by 381.70% in one year.
Market Cap
273.60M
Enterprise Value
509.18M
1-Year Change
381.70%
Ranking
Category
Stock Price
$4.05
Market Cap Chart
Since July 20, 2017, Cibus's market cap has decreased from $288.70M to $273.60M, a decrease of -5.23%. That is a compound annual growth rate of -0.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 215.50M | 128.04% |
| Dec 31, 2025 | 94.50M | 14.96% |
| Dec 31, 2024 | 82.20M | -80.39% |
| Dec 29, 2023 | 419.20M | 5,722.22% |
| Dec 30, 2022 | 7.20M | -91.22% |
| Dec 31, 2021 | 82.00M | -47.57% |
| Dec 31, 2020 | 156.40M | -32.29% |
| Dec 31, 2019 | 231.00M | -31.54% |
| Dec 31, 2018 | 337.40M | -44.70% |
| Dec 29, 2017 | 610.10M | 111.33% |
| Jul 20, 2017 | 288.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Context Therapeutics | 266.45M |
| Orchestra BioMed Holdings | 263.69M |
| Palisade Bio | 259.27M |
| Fennec Pharmaceuticals | 259.23M |
| Inhibikase Therapeutics | 258.52M |
| Prelude Therapeutics | 254.61M |
| Surrozen | 252.55M |
| Alector | 241.69M |